000 | 01579 a2200469 4500 | ||
---|---|---|---|
005 | 20250515234345.0 | ||
264 | 0 | _c20110829 | |
008 | 201108s 0 0 eng d | ||
022 | _a1476-5365 | ||
024 | 7 |
_a10.1038/bmt.2010.187 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aGerull, S | |
245 | 0 | 0 |
_aCyclosporine levels and rate of graft rejection following non-myeloablative conditioning for allogeneic hematopoietic SCT. _h[electronic resource] |
260 |
_bBone marrow transplantation _cMay 2011 |
||
300 |
_a740-6 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _aAdult |
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aCyclosporine _xadministration & dosage |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 |
_aGraft Rejection _xetiology |
650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aImmunosuppression Therapy _xmethods |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMiddle Aged |
650 | 0 | 4 | _aRetrospective Studies |
650 | 0 | 4 | _aTransplantation Chimera |
650 | 0 | 4 |
_aTransplantation Conditioning _xadverse effects |
650 | 0 | 4 |
_aVidarabine _xanalogs & derivatives |
650 | 0 | 4 | _aWhole-Body Irradiation |
700 | 1 | _aArber, C | |
700 | 1 | _aBucher, C | |
700 | 1 | _aBuser, A | |
700 | 1 | _aGratwohl, A | |
700 | 1 | _aHalter, J | |
700 | 1 | _aHeim, D | |
700 | 1 | _aTichelli, A | |
700 | 1 | _aStern, M | |
773 | 0 |
_tBone marrow transplantation _gvol. 46 _gno. 5 _gp. 740-6 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1038/bmt.2010.187 _zAvailable from publisher's website |
999 |
_c20035501 _d20035501 |